Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia

被引：32

作者：

Chandesris, MO ^{[1
]}

Gayet, S ^{[1
]}

Schleinitz, N ^{[1
]}

Doudier, B ^{[1
]}

Harlé, JR ^{[1
]}

Kaplanski, G ^{[1
]}

机构：

[1] Hop Conception, Serv Med Interne, F-13005 Marseille, France

来源：

RHEUMATOLOGY | 2004年 / 43卷 / 04期

关键词：

D O I：

10.1093/rheumatology/keh080

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：532 / 533

页数：2

共 5 条

[1] Efficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitides:: an open pilot study on 10 patients [J].

Bartolucci, P ;

Ramanoelina, J ;

Cohen, P ;

Mahr, A ;

Godmer, P ;

Le Hello, C ;

Guillevin, L .

RHEUMATOLOGY, 2002, 41 (10) :1126-1132

[2] Extrahepatic manifestations associated with hepatitis C virus infection - A prospective multicenter study of 321 patients [J].

Cacoub, P ;

Renou, C ;

Rosenthal, E ;

Cohen, P ;

Loury, I ;

Loustaud-Ratti, V ;

Yamamoto, AM ;

Camproux, AC ;

Hausfater, P ;

Musset, L ;

Veyssier, P ;

Raguin, G ;

Piette, JC .

MEDICINE, 2000, 79 (01) :47-56

[3] Cryoglobulinemia vasculitis [J].

Cacoub, P ;

Costedoat-Chalumeau, N ;

Lidove, O ;

Alric, L .

CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (01) :29-35

[4] Increased soluble p55 and p75 tumour necrosis factor-α receptors in patients with hepatitis C-associated mixed cryoglobulinaemia [J].

Kaplanski, G ;

Marin, V ;

Maisonobe, T ;

Sbai, A ;

Farnarier, C ;

Ghillani, P ;

Thirion, X ;

Durand, JM ;

Harlé, JR ;

Bongrand, P ;

Piette, JC ;

Cacoub, P .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (01) :123-130

[5] Efficacy and safety of rituximab in type II mixed cryoglobulinemia [J].

Zaja, F ;

De Vita, S ;

Mazzaro, C ;

Sacco, S ;

Damiani, D ;

De Marchi, G ;

Michelutti, A ;

Baccarani, M ;

Fanin, R ;

Ferraccioli, G .

BLOOD, 2003, 101 (10) :3827-3834

← 1 →